Advances in Neoadjuvant Treatment for Early-Stage Breast Cancer
Neoadjuvant treatment is given as a first step to shrink a tumor before surgery. During our free September webinar, Lisa A. Carey, MD, will discuss
- The goals of neoadjuvant treatment
- The latest advances in chemotherapy, targeted therapy and hormonal therapies used as neoadjuvant treatments
- Who might get neoadjuvant treatment
- What to expect if you need this kind of therapy
About Our SpeakerLisa A. Carey, MD, is the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research at the University of North Carolina–Chapel Hill in the department of medicine, division of hematology and oncology. Dr. Carey is also physician-in-chief at UNC North Carolina Cancer Hospital and associate director of clinical research at UNC’s Lineberger Comprehensive Cancer Center.
She is an expert in triple-negative breast cancer and led the first trial looking at a new treatment regimen in this breast cancer subtype. Dr. Carey's research interests focus on breast cancer, including examining different subtypes of the disease, evaluating new chemotherapy medicines in early breast cancer and studying tumor traits that predict response to therapy.